These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16445355)

  • 1. Protein chips for high-throughput doping screening in athletes.
    Du H; Cheng J
    Expert Rev Proteomics; 2006 Feb; 3(1):111-4. PubMed ID: 16445355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of mass spectrometry at the Olympic Games.
    Hemmersbach P
    J Mass Spectrom; 2008 Jul; 43(7):839-53. PubMed ID: 18570181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of miniaturized competitive immunoassays on a protein chip as a screening tool for drugs.
    Du H; Wu M; Yang W; Yuan G; Sun Y; Lu Y; Zhao S; Du Q; Wang J; Yang S; Pan M; Lu Y; Wang S; Cheng J
    Clin Chem; 2005 Feb; 51(2):368-75. PubMed ID: 15563481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The history of doping and growth hormone abuse in sport.
    Holt RI; Erotokritou-Mulligan I; Sönksen PH
    Growth Horm IGF Res; 2009 Aug; 19(4):320-6. PubMed ID: 19467612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
    Smith R; Barnsley L; Kannangara S; Mace A
    Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
    Thevis M; Guddat S; Schänzer W
    Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doping in sport].
    Schänzer W; Thevis M
    Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid analysis and doping control 1960-1980: scientific developments and personal anecdotes.
    Shackleton C
    Steroids; 2009 Mar; 74(3):288-95. PubMed ID: 19013476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rogue athletes and recombinant DNA technology: challenges for doping control.
    Azzazy HM; Mansour MM
    Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and performance comparison of two carbon isotope ratio methods to control the misuse of androgens in humans.
    Saudan C; Emery C; Marclay F; Strahm E; Mangin P; Saugy M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2321-9. PubMed ID: 19117813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and old challenges of sports drug testing.
    Botrè F
    J Mass Spectrom; 2008 Jul; 43(7):903-7. PubMed ID: 18570180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond sports-doping headlines: the science of laboratory tests for performance-enhancing drugs.
    Hatton CK
    Pediatr Clin North Am; 2007 Aug; 54(4):713-33, xi. PubMed ID: 17723873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the legal framework applicable to the marker method for the detection of human growth hormone.
    Young RR; Bielak JS; Horvitz SL
    Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.